NCT00318812View on ClinicalTrials.gov

Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2011

Study Completion Date

December 31, 2011

Conditions
AnemiaRenal Failure
Interventions
DRUG

Heme Iron Polypeptide (Proferrin)

Heme iron polypeptide 11mg po tid for 6 months

DRUG

Iron sucrose (Venofer)

Iron sucrose infusion IV q month x 6 months

Trial Locations (1)

K1H 7W9

The Ottawa Hospital Research Institute, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER